Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.
1 other identifier
observational
700
0 countries
N/A
Brief Summary
Options for coronary revascularization include stent implantation and coronary bypass surgery. Both modalities have their unique advantages and disadvantages in terms of clinical outcomes as well as financial impact on the medical system. We wish to investigate the late results of patients undergoing coronary revascularization, the need for re-hospitalization, re-intervention, patient satisfaction as well as the financial burden on the medical system. The study will be conducted by historical prospective review of hospital records in conjunction with records of the medical insurance companies ("HMO's").
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2006
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2006
CompletedFirst Posted
Study publicly available on registry
November 1, 2006
CompletedStudy Start
First participant enrolled
November 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedMay 27, 2011
May 1, 2011
October 31, 2006
May 26, 2011
Conditions
Keywords
Eligibility Criteria
Patients which are insured in the relevant HMO's and suffer from a multi-vessel coronary disease and were treated during 2000-2004
You may qualify if:
- Patients which are insured in the relevant HMO's and suffer from a multi-vessel coronary disease with occlusion of at least 70% of at least two of the main coronary vessels.
You may not qualify if:
- Non multi- vessel Disease
- Any additional cardiac disease
- Valvular
- Low EF (\<30%)
- Liver disease - according to liver enzymes
- Other cardiac treatment (past or immediate future)
- Active MI (24hrs before revascularization)
- Previous revascularization before beginning of follow up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shaare Zedek Medical Centerlead
- Hebrew University of Jerusalemcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amir Shmueli, PhD
The Hebrew University, School of Public Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 31, 2006
First Posted
November 1, 2006
Study Start
November 1, 2006
Study Completion
May 1, 2007
Last Updated
May 27, 2011
Record last verified: 2011-05